GURUFOCUS.COM » STOCK LIST » USA » NAS » SomaLogic Inc (NAS:SLGC) » Definitions » GF Value
Switch to:

SomaLogic GF Value

: $0.00 (As of Today)
View and export this data going back to 2021. Start your Free Trial

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2022-08-09), SomaLogic's share price is $4.07. SomaLogic's GF Value is $0.00. Therefore, SomaLogic's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes SomaLogic is Not Valued.


SomaLogic  (NAS:SLGC) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

SomaLogic's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=4.07/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SomaLogic GF Value Related Terms

Thank you for viewing the detailed overview of SomaLogic's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


SomaLogic Business Description

SomaLogic logo
Traded in Other Exchanges
Address
2945 Wilderness Place, Boulder, CO, USA, 80301
SomaLogic Inc delivers precise and actionable health-management information that helps individuals to optimize their personal health and wellness throughout their lives. This information, to be provided through a global network of partners and users, is derived from SomaLogic's personalized measurement of changes in an individual's proteins over time.
Executives
Blakeman Shaun M. officer: Chief Financial Officer C/O CANTEL MEDICAL CORP. 150 CLOVE ROAD LITTLE FALLS NJ 07424
Margulies Anne H. director C/O HENRY SCHEIN, INC. 135 DURYEA ROAD MELVILLE NY 11747
Post Richard A director 998 LACOSTA LANE LANE TREE CO 80124
Casdin Eli director 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019
Cox Troy director C/O FOUNDATION MEDICINE, INC. C/O FOUNDATION MEDICINE, INC., 150 SECON CAMBRIDGE MA 02141
Meisel Ted D director
Barchi Robert director
Quake Stephen director C/O FLUIDIGM CORPORATION 7000 SHORELINE COURT, SUITE 100 SOUTH SAN FRANCISCO CA 94080
Lillis Charles M. director 13 CASTLE PINES DRIVE N CASTLE ROCK CO 80108
Harris Melody officer: President and COO 4801 WEST BYRON PLACE DENVER CO 80211
Gutierrez Ruben officer: General Counsel 6435 AVENIDA WILFREDO LA JOLLA CA 92037
Graves Amy officer: Chief Accounting Officer 926 PENDLETON AVENUE LONGMONT CO 80504
Smythe Roy director, officer: Chief Executive Officer 935 10TH STREET BOULDER CO 80302
M-lsh Ii Llc 10 percent owner 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
C-lsh Ii Llc 10 percent owner 1350 6TH AVENUE SUITE 2600 NEW YORK NY 10019

SomaLogic Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)